PRECISION LONGEVITY PLATFORM

Welcome back, Michael

Your baseline assessment and physician review are ready.

MA
Michael A.FYA Member · ID 1048
Portal review prototypeDesigned from the approved FYA male and female laboratory panel profiles. Patient values are illustrative.

YOUR HEALTH SNAPSHOT

Four priorities.
One coordinated plan.

Your care team has reviewed your baseline profile and identified the areas that deserve the most attention over the next 120 days.

76Health overview
Illustrative score

NEXT MILESTONE

Day 120

Follow-up blood draw

Planned for 3 January 2027

12 days completed
Profile tests10ordered from your panel
Within range31baseline markers
Needs attention4physician reviewed
Formula statusActiveFormula 01

CLINICAL PRIORITIES

Where we are focusing

YOUR DAILY FORMULA

GlowMix · Formula 01

Personalized from your biomarkers and prepared fresh by a licensed FYA partner pharmacy.

FYA GlowMix sachet
One sachet dailyMix with water · Take with breakfast

YOUR CARE JOURNEY

Every step stays connected

✓AssessmentComplete
✓Blood drawComplete
✓ReviewComplete
4GlowMixActive now
5RetestDay 120

BASELINE LABORATORY PROFILE · 05 SEP 2026

Blood test results

Custom Male Panel · Test code 721Z · Specimens: 1 SST, 1 LAV

Clinical reviewComplete
Source panel721Z
Collected05 Sep 2026
Released08 Sep 2026
Clinical data design rule

The production portal will preserve the laboratory’s original result, unit and reference interval. FYA status and physician interpretation will be displayed separately, with an audit trail and physician approval before client release.

PERSONALLY REVIEWED

Messages from your medical team

Clinical guidance linked directly to your baseline profile.

✓ Review complete
MK

Dr. Marc S. Kaufman, MD

Medical Director · Internal Medicine

40+ years of clinical experience

Dear Michael,

I have reviewed your laboratory profile and the health information you provided. Your personalized program has been designed around your current biomarkers, with particular attention to vitamin D status, metabolic balance, cardiovascular markers and hormone monitoring.

Your results must be understood as part of your complete clinical picture. Consistency with your daily plan and the lifestyle guidance provided will allow us to evaluate meaningful change at your 120-day reassessment.

Warmly,
Dr. Marc S. Kaufman

PHYSICIAN SIGNATURE
NS

Dr. Nader Saab

Clinical Partner · Aesthetic & Wellness Medicine

Dear Michael,

Your FYA assessment gives us a clear and measurable starting point. For the next 120 days, consistency matters most: follow your daily formula, prioritize restorative sleep, remain active and keep your care team informed of any change in your health or medication.

I look forward to reviewing your progress.

With best wishes,
Dr. Nader Saab

PHYSICIAN SIGNATURE

FORMULA 01 · ACTIVE

Your personalized GlowMix

Prepared specifically for Michael A. from his reviewed biomarkers.

30 daily sachets

Clinical objectives

01Micronutrient supportSupport selected nutritional markers within the physician-approved protocol.
02Metabolic supportComplement personalized nutrition, sleep and movement guidance.
03Healthy-aging foundationDaily support with progress measured against baseline at day 120.

Daily use

1
sachet every day

Mix into 250–300 mL of water and take with breakfast unless your clinician advises otherwise.

Your formula complements medical care. It does not diagnose, treat, cure or replace prescribed medication.

MEASURABLE PROGRESS

Baseline versus day 120

Your follow-up results will appear beside baseline values using the same units and reference context.

Day 12 of 120
BiomarkerBaselineDay 120Change
Baseline
Reassessment

Your comparison is being built

Your care coordinator will arrange your follow-up blood draw before day 120.